INS and Hypoglycemia: Although the administration route is relatively invasive, pre-clinical and clinical tests of intraperitoneal insulin delivery have shown that this route may have advantages compared to traditional insulin delivery methods, including more stable glucose levels and less time spent in hyperglycemia and hypoglycemia in diabetic patients [197, 198].